Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01670136 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Sildenafil in Premature Infants
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01670136 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants.
The verdict
NCT01670136, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the safety and dosing of sildenafil in infants.
Interventions
- DRUG 1 dose of sildenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01670136
The ClinicalTrials.gov registry entry for NCT01670136 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1 dose of sildenafil is the first listed.
NCT01670136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01670136 about?
NCT01670136 is a clinical study titled "Pharmacokinetics of Sildenafil in Premature Infants". The purpose of this study is to learn more about the safety and dosing of sildenafil in infants.
What is the current status of trial NCT01670136?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2013-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01670136?
The interventions under investigation include: 1 dose of sildenafil (DRUG).
Who is sponsoring clinical trial NCT01670136?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.